Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan, Graeme G; Epstein, Joel B; Tu, Dongsheng; El Sayed, Samy; Bezjak, Andrea; Ottaway, Jon; Pater, Joe.
; 27(5): 421-8, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15782422
Neutron Beam Radiation Therapy: An Overview of Treatment and Oral Complications When Treating Salivary Gland Malignancies.
Low-level Laser Therapy: A Review of Its Applications in the Management of Oral Mucosal Disorders.
Salivary gland and associated complications in head and neck cancer therapy.
CE: Oral Care for Head and Neck Cancer Symptom Management.
Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.
Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation.
Two-stage autotransplantation of human submandibular gland: a novel approach to treat postradiogenic xerostomia.
Radiotherapy and the oral environment the effects of radiotherapy on the hard and soft tissues of the mouth and its management.
Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.